Slide Show: Labs and Ebola

Slideshow

Due to a heightened concern in the United States about Ebola, the Centers for Disease Control and Prevention (CDC) has issued guidance for clinical laboratories on testing needed for the assessment and care of patients for which Ebola Virus Disease (EVD) is a concern, while minimizing risk to laboratory personnel. This document updates and replaces the previously issued guidance, "How U.S. Laboratories Can Safely Manage Specimens from Persons Under Investigation for Ebola Virus Disease."

Recent Videos
Andreea Capilna, MD, PhD
Meet the Infection Control Today Editorial Advisory Board Members: Priya Pandya-Orozco, DNP, MSN, RN, PHN, CIC.
Meet Infection Control Today's Editorial Board Member: Tommy Davis, PhD, ACHE, APIC, BLS
Fungal Disease Awareness Week
Meet Shannon Simmons, DHSc, MPH, CIC.
Meet Matthew Pullen, MD.
Clostridioides difficile (Adobe Stock 260659307 by gaetan)
David Levine, PhD, DPT, MPH, FAPTA
Weekly Rounds with Infection Control Today
Related Content
Prevent long COVID. (Image courtesy of author.)

Long COVID: Urgent Findings, Including Brain Alterations, Call for Renewed Public Health Focus

Kevin Kavanagh, MD
October 21st 2024
Article

New research highlights long COVID’s global impact, cognitive decline, and societal consequences, urging renewed focus on prevention, including vaccination, mask use, and better air quality.

Health care worker with elderly patient (Adobe Stock 403477756)

Study Highlights Successes and Challenges in Implementing Enhanced Barrier Precautions in Nursing Homes

Tori Whitacre Martonicz;Stephanie Mayoryk, MAS, BSN, RN, CIC
October 21st 2024
Article

Research finds Enhanced Barrier Precautions reduce MDRO transmission in nursing homes, though challenges persist with gown usage, education, and comfort during high-contact care activities.

Neisseria gonorrhoeae (Adobe Stock 248386948 by Design Cells)

New Antibiotic Zoliflodacin Offers Hope Against Multidrug-Resistant Gonorrhea

John Parkinson
October 18th 2024
Article

The rise of multidrug-resistant gonorrhea highlights the urgent need for new therapies. Zoliflodacin, a promising oral antibiotic, shows effectiveness in late-stage trials.

Groundbreaking Sustainability and Cost Reducing Disinfectant Wipe Innovation

Groundbreaking Sustainability and Cost Reducing Disinfectant Wipe Innovation

October 17th 2024
Article
FDA sign (Adobe Stock, unknown)

FDA Places Clinical Hold on Novavax COVID-19-Influenza Combination Vaccine Due to Adverse Event

Matt Hoffman
October 17th 2024
Article

Novavax’s COVID-19-Influenza Combination vaccine faces a clinical hold after a trial participant developed motor neuropathy, pending further investigation by the FDA.

Clean Hospital Day interview by Infection Control Today.

Vileda Professional Partners With Clean Hospitals to Promote Sustainable Cleaning Solutions in Health Care

Tori Whitacre Martonicz
October 16th 2024
Article

Paul Harleman of Vileda Professional discusses their partnership with Clean Hospitals, emphasizing innovation, sustainability, and global efforts to improve hospital hygiene and safety.